Lunai Bioworks (LNAI) Other Accumulated Expenses (2020 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Other Accumulated Expenses of $364632.0 in Q1 2026, up 390.46% quarter-over-quarter from $74345.0 in Q4 2025, and down 33.25% on a YoY basis from $546265.0 in Q1 2025.
Lunai Bioworks (LNAI) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Lunai Bioworks' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $364632.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 33.25% year-over-year to $364632.0; the TTM figure through Mar 2026 stood at $364632.0 (down 33.25% YoY), while the FY2025 annual figure was $378282.0, up 28.07% from the prior year.
- Other Accumulated Expenses was $364632.0 for Q1 2026 at Lunai Bioworks, up from $74345.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $875415.0 in Q4 2022 to a low of $12030.0 in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $344545.1 across 5 years, with a median of $295361.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses soared 3520.26% in 2022, then tumbled 90.91% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $875415.0 in 2022, then fell by 23.54% to $669384.0 in 2023, then grew by 22.19% to $817908.0 in 2024, then sank by 90.91% to $74345.0 in 2025, then surged by 390.46% to $364632.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $364632.0 (Q1 2026), $74345.0 (Q4 2025), and $71429.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364,632.00 |
| Dec 31, 2025 | 74,345.00 |
| Sep 30, 2025 | 71,429.00 |
| Jun 30, 2025 | 378,282.00 |
| Mar 31, 2025 | 546,265.00 |
| Dec 31, 2024 | 817,908.00 |
| Sep 30, 2024 | 102,741.00 |
| Jun 30, 2024 | 295,361.00 |
| Mar 31, 2024 | 519,427.00 |
| Dec 31, 2023 | 669,384.00 |
| Jun 30, 2023 | 184,733.00 |
| Dec 31, 2022 | 875,415.00 |
| Sep 30, 2022 | 35,540.00 |
| Jun 30, 2022 | 220,685.00 |
| Mar 31, 2022 | 12,030.00 |
| Dec 31, 2021 | 24,181.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 90,602.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | 24,181.00 |